Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$23.26
+2.2%
$22.55
$18.70
$29.55
$1.08B1.79420,684 shs503,412 shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$128.39
-1.8%
$141.66
$123.00
$225.00
$3.79B1.25552,018 shs301,417 shs
Envista Holdings Corporation stock logo
NVST
Envista
$20.39
+1.1%
$18.26
$14.22
$23.00
$3.46B12.50 million shs1.00 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$59.00
+1.4%
$57.97
$47.04
$103.81
$3.20B1.07843,675 shs229,134 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.00%+8.24%+8.19%+11.40%+16.13%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
0.00%-3.06%-5.45%-9.26%-4.03%
Envista Holdings Corporation stock logo
NVST
Envista
0.00%+3.58%+9.12%+31.80%+25.09%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.00%+3.67%-9.30%+15.17%-7.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.1063 of 5 stars
3.53.00.00.02.62.50.6
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.8514 of 5 stars
4.41.00.04.83.32.51.9
Envista Holdings Corporation stock logo
NVST
Envista
3.7745 of 5 stars
2.23.00.03.82.90.01.9
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.4065 of 5 stars
3.41.00.00.02.42.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.00
Buy$31.1733.99% Upside
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.73
Moderate Buy$211.9165.06% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.23-0.78% Downside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.86
Moderate Buy$90.0052.54% Upside

Current Analyst Ratings Breakdown

Latest BLFS, INSP, NVST, and PRCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$21.00 ➝ $23.00
5/13/2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$30.00 ➝ $30.00
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$220.00 ➝ $200.00
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$235.00 ➝ $195.00
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$195.00 ➝ $174.00
5/6/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$230.00 ➝ $236.00
5/5/2025
Envista Holdings Corporation stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $18.00
5/2/2025
Envista Holdings Corporation stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$21.00
4/30/2025
Envista Holdings Corporation stock logo
NVST
Envista
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $17.00
4/29/2025
Envista Holdings Corporation stock logo
NVST
Envista
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $23.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$82.25M13.43$0.12 per share186.43$7.52 per share3.09
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$802.80M4.72$1.71 per share75.20$23.01 per share5.58
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.38$1.66 per share12.27$17.05 per share1.20
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$224.50M14.54N/AN/A$7.71 per share7.65
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$20.18M-$0.29N/AN/AN/A-11.81%-0.66%-0.58%8/14/2025 (Estimated)
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$53.51M$2.1759.1639.871.977.92%10.00%8.68%8/5/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B-$6.53N/A16.851.30-44.90%4.07%2.25%8/6/2025 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$91.41M-$1.70N/AN/AN/A-36.20%-28.09%-20.02%7/30/2025 (Estimated)

Latest BLFS, INSP, NVST, and PRCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.03$0.04+$0.07-$0.01$22.22 million$23.94 million
5/5/2025Q1 2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.23$0.10+$0.33$0.10$194.89 million$201.32 million
5/1/2025Q1 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
4/24/2025Q1 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.01
4.73
3.74
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
9.01
7.44
Envista Holdings Corporation stock logo
NVST
Envista
0.43
2.12
1.82
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.13
8.95
7.75

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.10%
Envista Holdings Corporation stock logo
NVST
Envista
1.30%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44047.50 million46.46 millionOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,24629.49 million28.29 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300169.49 million167.28 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43055.33 million51.68 millionOptionable

Recent News About These Companies

PRCT PROCEPT BioRobotics Corporation - Seeking Alpha
Procept BioRobotics price target lowered to $84 from $104 at BofA
PROCEPT BioRobotics (PRCT) Gets a Hold from BTIG
Procept BioRobotics sees FY25 revenue $323M, consensus $321.67M

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$23.26 +0.51 (+2.24%)
Closing price 07/3/2025 03:36 PM Eastern
Extended Trading
$23.68 +0.41 (+1.78%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$128.38 -2.34 (-1.79%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$128.38 0.00 (0.00%)
As of 07/3/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Envista stock logo

Envista NYSE:NVST

$20.39 +0.22 (+1.09%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$20.42 +0.03 (+0.15%)
As of 07/3/2025 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$59.00 +0.82 (+1.41%)
Closing price 07/3/2025 03:40 PM Eastern
Extended Trading
$58.40 -0.60 (-1.02%)
As of 07/3/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.